GB0501741D0 - Antibody - Google Patents

Antibody

Info

Publication number
GB0501741D0
GB0501741D0 GBGB0501741.3A GB0501741A GB0501741D0 GB 0501741 D0 GB0501741 D0 GB 0501741D0 GB 0501741 A GB0501741 A GB 0501741A GB 0501741 D0 GB0501741 D0 GB 0501741D0
Authority
GB
United Kingdom
Prior art keywords
immunoglobulins
detecting
bound
antibody
heavy chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0501741.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Binding Site Ltd
Original Assignee
Binding Site Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Binding Site Ltd filed Critical Binding Site Ltd
Priority to GBGB0501741.3A priority Critical patent/GB0501741D0/en
Publication of GB0501741D0 publication Critical patent/GB0501741D0/en
Priority to ES06703629.3T priority patent/ES2365626T7/es
Priority to AT06703629T priority patent/ATE502302T1/de
Priority to US11/883,003 priority patent/US7897353B2/en
Priority to PL10196249T priority patent/PL2306202T3/pl
Priority to DE602006020688T priority patent/DE602006020688D1/de
Priority to PT101962496T priority patent/PT2306202E/pt
Priority to PCT/GB2006/000267 priority patent/WO2006079816A1/en
Priority to ES10196249.6T priority patent/ES2455440T3/es
Priority to EP06703629.3A priority patent/EP1842071B3/en
Priority to DK10196249.6T priority patent/DK2306202T3/da
Priority to JP2007552716A priority patent/JP5431674B2/ja
Priority to EP10196249.6A priority patent/EP2306202B1/en
Priority to US13/011,146 priority patent/US8592561B2/en
Priority to US13/011,135 priority patent/US8415110B2/en
Priority to JP2013044306A priority patent/JP6007134B2/ja
Priority to JP2013221946A priority patent/JP5715671B2/ja
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB0501741.3A 2005-01-25 2005-01-27 Antibody Ceased GB0501741D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB0501741.3A GB0501741D0 (en) 2005-01-27 2005-01-27 Antibody
EP10196249.6A EP2306202B1 (en) 2005-01-27 2006-01-26 Method of detecting or monitoring a malignant plasma cell disease
ES10196249.6T ES2455440T3 (es) 2005-01-27 2006-01-26 Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas
DK10196249.6T DK2306202T3 (da) 2005-01-27 2006-01-26 Fremgangsmåde til påvisning eller overvågning af en malign plasmacellesygdom
US11/883,003 US7897353B2 (en) 2005-01-27 2006-01-26 Method of detecting or monitoring a malignant plasma cell disease
PL10196249T PL2306202T3 (pl) 2005-01-27 2006-01-26 Sposób wykrywania lub monitorowania złośliwej choroby nowotworowej komórek plazmatycznych
DE602006020688T DE602006020688D1 (de) 2005-01-27 2006-01-26 Verfahren zum nachweis oder zur überwachung einer bösartigen plasmazellkrankheit
PT101962496T PT2306202E (pt) 2005-01-27 2006-01-26 Método para detectar ou para monitorizar no plasma uma doença celular maligna
PCT/GB2006/000267 WO2006079816A1 (en) 2005-01-27 2006-01-26 Method of detecting or monitoring a malignant plasma cell disease
ES06703629.3T ES2365626T7 (es) 2005-01-27 2006-01-26 Método de detección o seguimiento de una enfermedad maligna de las células plasmáticas
EP06703629.3A EP1842071B3 (en) 2005-01-27 2006-01-26 Method of detecting or monitoring a malignant plasma cell disease
AT06703629T ATE502302T1 (de) 2005-01-27 2006-01-26 Verfahren zum nachweis oder zur überwachung einer bösartigen plasmazellkrankheit
JP2007552716A JP5431674B2 (ja) 2005-01-27 2006-01-26 悪性プラズマ細胞疾患の検出又はモニタリング方法
US13/011,135 US8415110B2 (en) 2005-01-25 2011-01-21 Method of detecting or monitoring a malignant plasma cell disease
US13/011,146 US8592561B2 (en) 2005-01-25 2011-01-21 Antibodies for detecting or monitoring a malignant plasma cell disease
JP2013044306A JP6007134B2 (ja) 2005-01-27 2013-03-06 免疫グロブリン重鎖−軽鎖対に特異的である単離抗体又はその断片
JP2013221946A JP5715671B2 (ja) 2005-01-27 2013-10-25 悪性プラズマ細胞疾患の検出又はモニタリング方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0501741.3A GB0501741D0 (en) 2005-01-27 2005-01-27 Antibody

Publications (1)

Publication Number Publication Date
GB0501741D0 true GB0501741D0 (en) 2005-03-02

Family

ID=34259791

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0501741.3A Ceased GB0501741D0 (en) 2005-01-25 2005-01-27 Antibody

Country Status (11)

Country Link
US (3) US7897353B2 (enExample)
EP (2) EP2306202B1 (enExample)
JP (3) JP5431674B2 (enExample)
AT (1) ATE502302T1 (enExample)
DE (1) DE602006020688D1 (enExample)
DK (1) DK2306202T3 (enExample)
ES (2) ES2365626T7 (enExample)
GB (1) GB0501741D0 (enExample)
PL (1) PL2306202T3 (enExample)
PT (1) PT2306202E (enExample)
WO (1) WO2006079816A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0608444D0 (en) 2006-04-27 2006-06-07 Binding Site The Ltd Dialysis
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain
SG174992A1 (en) 2009-04-01 2011-11-28 Genentech Inc Anti-fcrh5 antibodies and immunoconjugates and methods of use
GB0914535D0 (en) * 2009-08-19 2009-09-30 Binding Site Group The Ltd Prognosis assay
GB201001946D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Cancer prognostic assay
GB201001950D0 (en) * 2010-02-05 2010-03-24 Binding Site Group The Ltd Infection prognostic assay
GB201012049D0 (en) 2010-07-19 2010-09-01 Binding Site Group The Ltd Competition assay
GB201203938D0 (en) 2012-03-06 2012-04-18 Binding Site Group The Ltd Assay system
US9550004B2 (en) 2013-09-06 2017-01-24 Sensor Electronic Technology, Inc. Ultraviolet diffusive illumination
US10267806B2 (en) 2014-04-04 2019-04-23 Mayo Foundation For Medical Education And Research Isotyping immunoglobulins using accurate molecular mass
GB201511364D0 (en) * 2015-06-29 2015-08-12 Binding Site Group The Ltd Method of detecting or monitoring an IgG4-related disease
GB2541027A (en) * 2015-08-07 2017-02-08 The Binding Site Group Ltd Treatment
US12153052B2 (en) 2017-09-13 2024-11-26 Mayo Foundation For Medical Education And Research Identification and monitoring of immunoglobulin J chains
US11946937B2 (en) 2017-09-13 2024-04-02 Mayo Foundation For Medical Education And Research Identification and monitoring of apoptosis inhibitor of macrophage
WO2021202992A2 (en) * 2020-04-03 2021-10-07 Lawrence Loomis Rapid point of care assay for the detection of the asymptomatic carrier state of covid-19

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907502A (en) 1973-12-11 1975-09-23 Miless L Brink Method for identifying Bence Jones proteins
EP0044219A1 (en) 1980-07-16 1982-01-20 Unilever Plc Methods of immuno analysis using monoclonal antibodies
JPS63139199A (ja) * 1986-12-01 1988-06-10 Wakunaga Pharmaceut Co Ltd 抗ヒトＩｇＥモノクロ−ナル抗体及びその用途
ES2150428T3 (es) 1987-04-27 2000-12-01 Unilever Nv Ensayos de union especifica.
US4983530A (en) * 1988-01-29 1991-01-08 E. I. Du Pont De Nemours And Company Sandwich immunoassay for determination of total monoclonal IGG
US5185066A (en) * 1988-08-11 1993-02-09 Helena Laboratories Corporation Immunofixation electrophoresis control system
JPH03199966A (ja) * 1989-12-27 1991-08-30 Kazutomo Wakasugi 遊離型ｌ鎖の測定方法
JPH04262792A (ja) * 1990-01-12 1992-09-18 Takeda Chem Ind Ltd 蛋白質の精製法
US5228960A (en) * 1992-07-17 1993-07-20 Beckman Instruments, Inc. Analysis of samples by capillary electrophoretic immunosubtraction
US5552277A (en) * 1994-07-19 1996-09-03 The Johns Hopkins University School Of Medicine Genetic diagnosis of prostate cancer
EP0862584B1 (en) 1995-11-03 2004-12-22 The Binding Site Limited Production of antibodies
GB9718911D0 (en) * 1997-09-05 1997-11-12 Orion Yhtymae Oy Monoclonal antibodies
ATE301131T1 (de) * 1998-11-19 2005-08-15 Elan Corp Plc Gegen gastrointestinale transport rezeptoren gerichtete retro-invertierte peptide und deren verwendung
US20040163137A1 (en) * 2001-02-20 2004-08-19 Caroline Barry PG-3 and biallelic markers thereof
US20020182748A1 (en) 2001-03-30 2002-12-05 Reardon Paul C. Method and device for testing for Bence-Jones Protein
CA2468950A1 (en) * 2001-11-27 2003-06-05 Mochida Pharmaceutical Co., Ltd. Anti-il13 receptor .alpha.1 neutralizing antibody
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
AU2004210975B2 (en) * 2003-02-10 2008-04-10 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
WO2004073656A2 (en) * 2003-02-20 2004-09-02 Seattle Genetics, Inc. Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
JP4473257B2 (ja) * 2003-04-02 2010-06-02 エフ．ホフマン−ラ ロシュ アーゲー インスリン様成長因子ｉ受容体に対する抗体及びその使用
JP4286256B2 (ja) * 2003-11-19 2009-06-24 ヤマサ醤油株式会社 ベンスジョーンズ蛋白質の検定法
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
WO2005116651A2 (en) * 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein

Also Published As

Publication number Publication date
JP5715671B2 (ja) 2015-05-13
ES2365626T7 (es) 2014-06-04
JP2008528995A (ja) 2008-07-31
EP2306202B1 (en) 2013-12-18
PT2306202E (pt) 2014-02-27
WO2006079816A1 (en) 2006-08-03
DE602006020688D1 (de) 2011-04-28
US20110177535A1 (en) 2011-07-21
US20110177977A1 (en) 2011-07-21
DK2306202T3 (da) 2014-02-10
EP2306202A1 (en) 2011-04-06
US8415110B2 (en) 2013-04-09
US7897353B2 (en) 2011-03-01
JP6007134B2 (ja) 2016-10-12
ES2455440T3 (es) 2014-04-15
EP1842071B3 (en) 2014-02-26
JP2013147499A (ja) 2013-08-01
PL2306202T3 (pl) 2014-05-30
EP1842071B1 (en) 2011-03-16
JP2014025950A (ja) 2014-02-06
ES2365626T3 (es) 2011-10-07
EP1842071A1 (en) 2007-10-10
US20080166742A1 (en) 2008-07-10
ATE502302T1 (de) 2011-04-15
JP5431674B2 (ja) 2014-03-05
US8592561B2 (en) 2013-11-26

Similar Documents

Publication Publication Date Title
GB0501741D0 (en) Antibody
ATE410684T1 (de) Molekular-modifikations-assays
CA2548164A1 (en) Assay kit for detecting analytes of interest in samples
WO2008073222A3 (en) Indirect lateral flow sandwich assay
WO2009058902A3 (en) Methods and devices for analyte detection
WO2009117510A3 (en) Multi-wavelength analyses of sol-particle specific binding assays
WO2008007242A3 (en) Increased specificity of analyte detection by measurement of bound and unbound labels
WO2007035633A3 (en) Screening assays and methods
WO2008022152A3 (en) Optimized antibodies that target cd19
WO2004041061A3 (en) Substrates, devices, and methods for cellular assays
ATE274699T1 (de) Analytassay-vorrichtung mit vorabsorbieren-zone
WO2010049672A3 (en) Methods and products for measuring free immunoglobulin light chain molecules
ATE532830T1 (de) Langwellige thiolgruppenreaktive fluorophore
WO2008101177A3 (en) Ige antibodies to chimeric or humanized igg therapeutic monoclonal antibodies as a screening test for anaphylaxis
WO2006086208A3 (en) 5-fluoro-uracil immunoassay
WO2008076367A3 (en) Polymer-protein substrates for immunosorbent fluorescence assays
WO2010006201A3 (en) Methods of reducing non-specific interaction in metal nanoparticle assays
WO2001073443A3 (en) Methods and compositions for the simultaneous detection of multiple analytes
JP2008528995A5 (enExample)
ATE405837T1 (de) Festphase immunochromatographische testverfahren
WO2008081331A3 (en) Enhancing the level of antibody expression by framework re-engineering
WO2007001895A3 (en) Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase
ATE511650T1 (de) Verfahren zum nachweis von antikörpern einer bestimmten klasse über einen immunkomplex spezifischen antikörper
AU2003248619A1 (en) Method for the elimination of interferences in immunochromatographic assays
WO2002079783A3 (en) Method and device for testing for bence-jones protein

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)